Posted by on March 19, 2012 - 11:55am

Medical errors can occur anywhere in the health care system: In hospitals, clinics, surgery centers, doctors' offices, nursing homes, pharmacies, and patients' homes. Errors can involve medicines, surgery, diagnosis, equipment, or lab reports. They can happen during even the most routine tasks, such as when a hospital patient on a salt-free diet is given a high-salt meal. One in seven Medicare patients in hospitals experience a medical error.

Most errors result from problems created by today's complex health care system. But errors also happen when doctors and patients have problems communicating. These tips tell what you can do to get safer care.

What You Can Do to Stay Safe
The best way you can help to prevent errors is to be an active member of your health care team. That means taking part in every decision about your health care. Research shows that patients who are more involved with their care tend to get better results.

Medicines
1. Make sure that all of your doctors know about every medicine you are taking. This includes prescription and over-the-counter medicines and dietary supplements, such as vitamins and herbs. It's a good idea to bring all of your medicine/supplement bottles to your medical visits.

2. Make sure your doctor knows about any allergies and adverse reactions you have had to medicines. This can help you to avoid getting a medicine that could harm you.

3. When your doctor writes a prescription for you, make sure you can read it. If you cannot read your doctor's handwriting, your pharmacist might not be able to either.

4. Ask for information about your medicines in terms you can understand—both when your medicines are prescribed and when you get them:

  • What is the medicine for?
  • How am I supposed to take it and for how long?
  • What side effects are likely? What do I do if they occur?
  • Is this medicine safe to take with other medicines or dietary supplements I am taking?  What food, drink or activities should I avoid while taking it?

5. When you pick up your medicine from the pharmacy, ask: Is this the medicine that my doctor prescribed? (It's a good idea to look at the medicine--my husband once got a different shaped pill that ended up being a narcotic instead of his allergy medicine!)

6. If you have any questions about the directions on your medicine labels, ask. For example, ask if "four times daily" means taking a dose every 6 hours around the clock or just during regular waking hours.

7. Ask your pharmacist for the best device to measure your liquid medicine. For example, many people use household teaspoons, which often do not hold a true teaspoon of liquid. Special devices, like marked syringes, help people measure the right dose.

8. Ask for written information about the side effects your medicine could cause. If you know what might happen, you will be better prepared if it does or if something unexpected happens.

Hospital Stays
1.  If you are in a hospital, consider asking all health care workers who will touch you whether they have washed their hands. Handwashing can prevent the spread of infections in hospitals.

2.  When you are being discharged from the hospital, ask your doctor to explain the treatment plan you will follow at home. This includes learning about your new medicines, making sure you know when to schedule follow-up appointments, and finding out when you can get back to your regular activities.  It is important to know whether or not you should keep taking the medicines you were taking before your hospital stay. Getting clear instructions may help prevent an unexpected return trip to the hospital.

Surgery
1. If you are having surgery, make sure that you, your doctor, and your surgeon all agree on exactly what will be done.   Having surgery at the wrong site (for example, operating on the left knee instead of the right) is rare. But even once is too often. The good news is that wrong-site surgery is 100 percent preventable. Surgeons are expected to sign their initials directly on the site to be operated on before the surgery.

2. If you have a choice, choose a hospital where many patients have had the procedure or surgery you need.  Patients tend to have better results when they are treated in hospitals that have a great deal of experience with their condition.

Other Steps
1.  Speak up if you have questions or concerns. You have a right to question anyone who is involved with your care.

2.  Make sure that someone, such as your primary care doctor, coordinates your care. This is especially important if you have many health problems or are in the hospital.

3.  Make sure that all your doctors have your important health information. Do not assume that everyone has all the information they need.

4.  Ask a family member or friend to go to appointments with you. Even if you do not need help now, you might need it later.

5. . Know that "more" is not always better. It is a good idea to find out why a test or treatment is needed and how it can help you. You could be better off without it.

6. . If you have a test, do not assume that no news is good news. Ask how and when you will get the results.

7 . Learn about your condition and treatments by asking your doctor and nurse and by using other reliable sources. For example, treatment options based on the latest scientific evidence are available from the Effective Health Care Web site (http://www.effectivehealthcare.ahrq.gov/options). Ask your doctor if your treatment is based on the latest evidence.

Source:   20 Tips to Help Prevent Medical Errors. Patient Fact Sheet. AHRQ Publication No. 11-0089, September 2011. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/consumer/20tips.htm

Posted by on March 17, 2012 - 11:53am

Just 38 percent of sexually active young women were screened for chlamydia in the previous year, according to the most recent nationally representative estimate conducted by the Centers for Disease Control and Prevention. CDC recommends annual screening for all sexually active women aged 25 and under.

Overall testing rates remain low, although testing was most common among African-American women, those who had multiple sex partners, and those who received public insurance or were uninsured. Researchers find this encouraging because these are some of the groups at highest risk for chlamydia.

“This new research makes it clear that we are missing too many opportunities to protect young women from health consequences that can last a lifetime,” said Kevin Fenton, M.D., director of the CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention. “Annual chlamydia screening can protect young women’s reproductive health now and safeguard it for the future.”

Chlamydia is the most commonly reported infectious disease in the United States, and young people are most affected. Because people often do not have symptoms, many infections go undetected and untreated. Untreated chlamydia can have severe long-term health consequences, particularly for young women, including chronic pelvic pain, potentially fatal ectopic pregnancy and infertility.

CDC recommends that anyone diagnosed with chlamydia be retested three months after initial treatment to ensure that those who may have become reinfected can be promptly treated with antibiotics. However, additional data show that retesting rates remain low and many reinfections likely are being missed. By examining available data on more than 60,000 men and women who tested positive for chlamydia CDC  found that just 14 percent of men and 22 percent of women were retested within 30-180 days. Of those who were retested, a significant proportion again tested positive (25 percent of men and 16 percent of women).

“It is critical that health care providers are not only aware of the importance of testing sexually active young women every year for chlamydia infections, but also of retesting anyone who is diagnosed,” said Gail Bolan, M.D., director of the CDC’s Division of STD Prevention. “Chlamydia can be easily treated and cured with antibiotics, and retesting plays a vital role in preventing serious future health consequences.”

 

 

Posted by on March 15, 2012 - 11:13am

Margaret Sanger

In 1916, Margaret Sanger opened the first birth control clinic, and is quoted as saying:   "Women must have her freedom, the fundamental freedom of choosing whether or not she will be a mother and how many children she will have.  Regardless of what man's attitude may be, the problem is hers--and before it can be his, it is hers alone.  She goes through the vale of death alone, each time a babe is born.  As it is the right neither of man nor the state to coerce her into this ordeal, so it is her right to decide whether she will endure it."   This was said nearly a century ago..wonder what she would say to today's politicians?

Posted by on March 13, 2012 - 6:42am

Maintaining a healthy lifestyle from young adulthood into your 40s is strongly associated with low cardiovascular disease risk in middle age, according to a new Northwestern Medicine® study.

“The problem is few adults can maintain ideal cardiovascular health factors as they age,” said Kiang Liu, PhD, first author of the study. “Many middle-aged adults develop unhealthy diets, gain weight, and aren’t as physically active. Such lifestyles, of course, lead to high blood pressure and cholesterol, diabetes and elevated cardiovascular risk.”

“In this study, even people with a family history of heart problems were able to have a low cardiovascular disease risk profile if they started living a healthy lifestyle when they were young,” Liu said. “This supports the notion that lifestyle may play a more prominent role than genetics.”   Published Feb. 28 in the journal Circulation, this is the first study to show the association of a healthy lifestyle maintained throughout young adulthood and middle age with low cardiovascular disease risk in middle age.

The majority of people who maintained five healthy lifestyle factors from young adulthood (including a lean body mass index (BMI), no excess alcohol intake, no smoking, a healthy diet and regular physical activity) were able to remain in this low-risk category in their middle-aged years.

In the first year of the study, when the participants’ average age was 24 years old, nearly 44 percent had a low cardiovascular disease risk profile. Twenty years later, overall, only 24.5 percent fell into the category of a low cardiovascular disease risk profile.    Sixty percent of those who maintained all five healthy lifestyles reached middle age with the low cardiovascular risk profile, compared with fewer than 5 percent who followed none of the healthy lifestyles.

If the next generation of young people adopt and maintain healthy lifestyles, they will gain more than heart health, Liu stressed.

“Many studies suggest that people who have low cardiovascular risk in middle age will have a better quality of life, will live longer and will have lower Medicare costs in their older age,” he said. “There are a lot of benefits to maintaining a low-risk profile.”

Liu is a professor and the associate chair for research in the Department of Preventive Medicine at Northwestern University Feinberg School of Medicine.

Source:  Erin White, Northwestern NewsCenter

 

Posted by on March 11, 2012 - 7:48am

Dietary supplements are a $28 billion dollar business in America.  Thanks to 1994's Hatch Act, the Dietary Supplement Health and Education Act (DSHEA), pushed through Congress and released upon a then-unprotesting public by Utah's Sen. Orrin Hatch (R-UT), substances which may be benign, toxic, and everything in between, as long as they are sold as "dietary nutritional supplements," get a virtual free pass.

According to Dr. George Lundberg, member of the Institute of Medicine and former Editor-in-Chief of the Journal of the American Medical Association (JAMA), manufacturers of supplements can make "structure-function" claims, such as "supports sexual health," but not actual health claims (which the FDA defines as proof that the substance can be used to diagnose, treat,  cure or prevent any disease).

Part of the law mandates that ingredients brought to market after 1994, so-called "novel" ingredients -- and only those -- be shown to have passed safety tests.  Older ingredients got "grandfathered" in without the need to be proven either safe or effective.  There have been approximately 51,000 new ingredients brought to market since DSHEA passed, of which about 0.3% -- that's not a misprint, 170 out of 51,000 -- have documented safety tests.

Unfortunately, consumers are often under the impression that substances called "natural" must be safe and that includes vitamins, minerals, potions, herbals, biologicals, etc.  If a shopper has a question about the efficacy or danger of a supplement, they may simply ask the health-food store employee who is not required to have any kind of credentials.

According to Dr. Lundberg, "We Americans, so concerned about minute amounts of this or that chemical in our food and water, and ready to challenge our board-certified internist on treatment decisions, gobble down supplements with alarming obliviousness to their potential dangers and denial of the overwhelming absence of evidence of benefit."

A "Perspective" article in a recent New England Journal of Medicine by Dr. Pieter Cohen called for a tightening -- no, not even that, merely actually enforcing the law as written -- by having the FDA demand that, instead of pleading with, the supplement manufacturers supply the agency with at least the legal minimum of data on their products' safety.

 

Posted by on March 9, 2012 - 2:37pm

Women’s History Month is an important time of reflection and celebration for all Americans. We recognize the extraordinary accomplishments of women throughout history, and we celebrate the power of their vital contributions to science, medicine and women's empowerment. Here are a just a few of the many accomplishments done by women in the last century and a half.  Many of them were true pioneers in women's health!

1835, Harriot Kezie Hunt opens her own medical practice focusing on women and children.  Because she is female, she is barred from hospitals and lectures at Harvard.

1849, Elizabeth Blackwell becomes the first US woman to receive an MD degree.

1855,  physician Emeline Horton Cleveland practices gynecology and breaks down barriers against women doctors.  She performed operations to remove ovarian tumors; these are judged to be the first recorded instance of major surgery performed by a women.

1872, physician Mary Putnam Jacobi founds the Association for Advancement of the Medical Education of Women.

1895, Mary Engle Pennington is denied a BS degree at U of Pennsylvania because of her gender but later earns a PhD and does research on bacteria and refrigeration that leads to safer eggs, poultry and fish.

1905, biologist and cytogeneticist Nettie Stevens contributes to the understanding of chromosomes, particularly the X and Y chromosomes.

1916, Margaret Sanger opens the first birth control clinic, saying "Women must have her freedom, the fundamental freedom of choosing whether or not she will be a mother and how many children she will have.  Regardless of what man's attitude may be, the problem is hers--and before it can be his, it is hers alone.  She goes through the vale of death alone, each time a babe is born.  As it is the right neither of man nor the state to coerce her into this ordeal, so it is her right to decide whether she will endure it."

1917, microbiologist, Alice Evans discovers the bacterium responsible for undulant fever which leads to pasteurization of all milk.

1937, Hattie Alexander, bacteriologist and pediatrician, developed the first effective treatment for the once fatal influenza meningitis.

1947, biochemist and physician, Gerty Radniz Cori, was the first woman to receive a Nobel Prize in science for her work in understanding how the body metabolizes carbohydrates (the Cori cycle).

1952, Virginia Apner, physician, developed a series of rapid checks (Apner scores) still done today for use on newborns to determine if they need immediate medical attention.

1953, Mary Steichen Calderone become the medical director of Planned Parenthood and drew attention to women's health providers about the dangers of illegal abortion.

1962, pharmacologist and physician Frances Kelsey prevents the drug thalidomide, which causes birth defects, from entering the United States.

1965, Judith  Graham Pool identifies Factor VIII, the clotting factor that is responsible for the most common type of hemophilia.   She developed a way to manufacture it so it can be given to humans to stop them from dire bleeding episodes.

1977, physicist Rosalyn Yalow receives the Nobel Prize for her work in developing radioimmunoassay, a technique that uses radioactive isotopes to measure small amounts of biological substance what is widespread today.

1983, Sally Ride is the first American woman to orbit the earth while aboard the space shuttle Challenger.

1990, physician Antonia Novello is the first woman and first Latina appointed U.S.  surgeon general.

1991, cardiologist Bernadine Healy, became the first woman to head the US National Institutes of Health.  She was instrumental in creating the the Women's Health Initiative, in response to the lack of  research on older women.

2006, reproductive scientist, Teresa Woodruff, coins the term 'oncofertility' to represent the merging of two disciplines, fertility and cancer, to explore ways to to help women and girls who lose their fertility as a result of cancer treatments and to enable them to have children once their cancer is treated.

Today, women continue to face many obstacles when it comes to education and health but we are making progress.We are inspired by the great pioneers of our past, and we challenge Americans everywhere to consider how we each can make our own unique contribution to ensure justice in health care and to improve the lives of women and girls.

Source:  Her Story by Waisman and Tietjen, 2008

 

Posted by on March 8, 2012 - 9:21am

Babies are not able to metabolize or excrete caffeine very well, so a breastfeeding mother's consumption of caffeine may lead to caffeine accumulation and symptoms such as wakefulness and irritability, according to an interview with expert Ruth Lawrence, MD, published in Journal of Caffeine Research.  The interview is available on the Journal of Caffeine Research website.

Caffeine is found in a wide range of products in addition to coffee, tea, and chocolate, including soft drinks, sports drinks, and some over-the-counter medications. In a provocative discussion with Dr. Ruth Lawrence, Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Jack E. James, PhD, Editor-in-Chief of Journal of Caffeine Research, asks a variety of probing questions. Is there a safe level of caffeine intake while breastfeeding? Are there potential long-term effects of caffeine exposure on development and intellect? Can a baby whose mother consumed caffeine during pregnancy experience withdrawal if she then abstains from caffeine while breastfeeding? Dr. Lawrence bases her responses on the scientific and medical evidence related to caffeine exposure in breastfed babies, and distinguishes between what is and what is not well understood in this developing field of study.

"Usually a mother, particularly if she is breastfeeding, is cautioned to limit her caffeine intake," says Dr. Lawrence, who is Editor-in-Chief of the peer-reviewed journal Breastfeeding Medicine. After giving birth, mothers "should consume all things in moderation and try to avoid the excesses that might really add up to a lot of caffeine."
References:
*http://www.liebertpub.com/jcr

Citations:
Mary Ann Liebert, Inc./Genetic Engineering News. "Breastfeeding And Caffeine Consumption." Medical News Today. MediLexicon, Intl., 23 Feb. 2012. Web.
5 Mar. 2012. <http://www.medicalnewstoday.com/releases/241990.php>

Posted by on March 7, 2012 - 7:44am

 High heel shoes can cause a number of foot problems, yet most women aren’t willing to give their shoes the boot, according to podiatrists at Loyola University Health System (LUHS). Ingrown toenails are among the most common problems that result from high heels. This condition, also known as onychocryptosis, occurs when the toes compress together making the big toenails grow into the skin.

High heels and tight-fitting or pointed-toe shoes create chronic pressure on the big toenails and prevent them from growing properly. Additionally, shoe pressure can cause the nail to puncture the skin leading to infection. Other causes can include trauma to the nail or fungal infections.

“Ingrown toenails can be painful, but many women are willing to cope with the discomfort in order to continue wearing their high heels,” said Rodney Stuck, DPM, professor of Podiatry Medicine, LUHS. “However, more serious complications can arise and cause permanent damage to the toenail, if they are left untreated.”

Dr. Stuck encourages women who wear heels to take these steps to manage ingrown toenails and prevent infection:

•Cut out a cardboard tracing of each foot and attempt to place it in the shoe when shopping for a new pair. If it does not fit, then the shoes are too narrow;
•Refrain from wearing tight hosiery;
•Limit the amount of time in heels;
•Wear heels on days that require limited walking or standing;
•Trim toenails straight across the top;
•Short soak of feet in lukewarm, soapy water or Epsom salts;
•Dry feet and toes thoroughly with a clean towel;
•Use a mild antiseptic solution on the toes.

If pain, swelling and discharge develop, the toe is likely infected. It will need to be treated by a podiatrist who may remove a portion of the affected nail to aid in treating the infection. If the condition recurs or persists, permanent removal of the nail can be accomplished with a minor, in-office surgical procedure.

Dr. Stuck warns that people with diabetes should be particularly careful of ingrown toenails. These individuals may have poor circulation, which makes healing difficult. They also may be more susceptible to nerve damage from their diabetes, which can prevent them from feeling pain in their feet.  “If diabetic women do not feel discomfort, they may neglect to treat the ingrown toenails until it is too late,” Dr. Stuck said. “If ignored, this condition, which is easily treatable, can lead to an amputation.”

In general, if you give your feet the attention they need, they will look and feel healthy. A bit of extra care will allow women who prefer fashionable high heels to continue to wear them.

©2012 Newswise

Source: Loyola University Health System

Posted by on March 5, 2012 - 10:27am

Menopausal hormone therapy doesn't have to follow "the lowest dose for the shortest time" strategy for all women anymore, the North American Menopause Society said today.   The group endorsed a flexible approach to duration that takes into account the type and timing of therapy and individual patient characteristics in a statement in its journal, Menopause.

For women in their 50s, the absolute risks are low; younger women without a history of breast cancer can use replacement hormones at least until the normal menopause age around 51, and longer if needed for symptom management, according to the guidelines.

"No 'one size fits all' approach is acceptable anymore," JoAnn E. Manson, MD, DrPH, NCMP, of Harvard, and president of the society, said in answer to a query from ABC News and MedPage Today.

Manson's position is somewhat surprising since she was a principal investigator for the Women's Health Initiative, the landmark randomized trial that derailed the hormone therapy movement when it reported a link between Premarin (estrogen/progestin) and increased risk of breast cancer and thromboembolic conditions.

The new guidelines loosen up on timing, agreed Michelle P. Warren, MD, NCMP, of Columbia Presbyterian Medical Center in New York City, who was also involved with the guidelines.   Women who need hormone therapy can use it for as long as needed, she said in an interview.    That shift should be reassuring for many women, Manson suggested.

When the Women's Health Initiative studies indicated elevated breast cancer and heart disease risk with hormone therapy in its postmenopausal population a decade ago, prescriptions dropped precipitously across the country.   Recommendations followed suit, urging cautious, sparing use of the drugs.

Fear of prescribing to women with any suggestion of heart disease, even the common symptom of palpitations, led to "a whole generation of women who were really suffering," Warren noted.

Now with longer-term follow-up available from that and other studies, perspectives are changing, explained Manson, who serves as an investigator with the ongoing Nurses' Health Study, an observational study that was once used to bolster use of hormone therapy.  Last summer, the Endocrine Society also called for rethinking the established line on menopausal hormone therapy, stating that risks and benefits vary by age and time since menopause.

The menopause society's consensus group concluded that the estrogen-only (ET) formulations (typically used for women without a uterus) can be used for seven years without increasing risk of breast cancer, while combination estrogen-progestin therapy (EPT) increases that risk after three to five years of use.

The recommendation for duration of therapy differs for EPT and ET. For EPT, duration is limited by the increased risk of breast cancer and breast cancer mortality associated with three to five years of use; for ET, a more favorable benefit/risk profile was observed during a mean of seven years of use and four years of follow-up, a finding that allows more flexibility in duration of use.

The Women's Health Initiative and Nurses' Health Study both pointed to a possible reduced risk if use didn't start immediately after menopause.   However, the evidence for this "gap theory" (also called the critical window hypothesis)  isn't very solid and menopausal symptoms are usually worse in the first two to five years, Warren said in an email to ABC News/MedPage Today.

The bigger clinical impact from the guidelines is likely to come from its conclusions on cardio- and cerebrovascular risks, she suggested.   With estrogen alone, women in their 50s in the Women's Health Initiative actually had a reduced risk of combined endpoints including coronary heart disease and total myocardial infarction.

With combined estrogen and progestin, that trial showed an absolute increase in heart disease by an estimated eight cases per 10,000 women per year, whereas observational studies had found a longer duration of use associated with a reduced risk.

The potentially reduced coronary heart disease risk among women who used hormone therapy for five or more years was "not conclusive and should be considered in light of other factors altered by duration of therapy, such as breast cancer," the statement warned.

There was a clear differentiation in risk by timing of hormone therapy after menopause, though, in the opposite direction than for breast cancer risk.  Both unopposed estrogen and estrogen with progestin were associated with elevated coronary heart disease risk when therapy started more than 10 years after menopause.

For stroke, hormone therapy had appeared to raise risk overall, with eight additional strokes per 10,000 women per year of combined hormone therapy and 11 extra with estrogen only.  But recent analyses of the two together found no significant stroke risk for women ages 50 to 59 at initiation, the statement noted.

"They have essentially rescinded the position concerning the heart data as long as you start within 10 years of menopause commencing," Warren summarized.

However, Marcia Stefanick, MD, of Stanford University, who had been involved with the Women's Health Initiative steering committee, took issue with that conclusion, calling it misleading.The analysis actually showed no interaction with age for stroke risk, which means all age groups are at elevated risk, she told ABC News/MedPage Today.Another problem was that the women on unopposed estrogen in the Women's Health Initiative only used the drug for an average of 3.5 years because so many discontinued.

"I don't think we have data suggesting that you can go beyond three to five years," she said. "It is misleading to say [estrogen is safe for] seven or more years."

The NAMS statement urged clinicians to consider a number of additional factors when considering hormone therapy for patients:

  • A woman's individual risk and history of venous thrombosis, heart disease, stroke, and breast cancer
  • Route of administration and dosing, as transdermal and low-dose oral estrogen are associated with lower venous thromboembolism and stroke risks than standard oral estrogen doses
  • Type of symptoms, with low-dose, local administration of estrogen when only vaginal symptoms are present

Further research is still needed, especially in interpreting individual risk and assessing long-term implications, the statement noted.

By Crystal Phend, Senior Staff Writer, MedPage Today

Primary source: Menopause: The Journal of The North American Menopause Society
Source reference:
"The 2012 hormone therapy position statement of the North American Menopause Society" Menopause 2012; 19: 257-271.

Posted by on March 1, 2012 - 12:35pm

BULLETIN:   Our previous blog discussed this amendment.   We're delighted to report that Senate has voted 51-48 against an amendment by Sen. Roy Blunt (R-Mo.) that would allow insurers to deny coverage of health services -- such as birth control -- if an employer objected on religious or moral grounds.

Pages